GCC19CART Trademark

Trademark Overview


On Wednesday, September 15, 2021, a trademark application was filed for GCC19CART with the United States Patent and Trademark Office. The USPTO has given the GCC19CART trademark a serial number of 97029671. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, May 29, 2024. This trademark is owned by Innovative Cellular Therapeutics Holdings, Ltd.. The GCC19CART trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Stem cell therapy services; Immunotherapy services in the nature of medical services; collection and preservation of biological tissue, blood and cells; Medical diagnostic testing, monitoring, and reporting services; Medical treatment of of cancer such as colon carcinoma, lymphoid malignancy, pancreatic cancer, breast cancer, lung cancers, ovarian cancer, prostate cancer, and autoimmune diseases such as Systemic lupus erythematosus (SLE); Health care services, namely, providing a database in the field of cell therapy such as Chimeric Antigen Receptor therapy, TCR (T-Cell Receptor) therapy, TIL (tumor-infiltrating lymphocyte) therapy, Natural Killer (NK) cell therapy, and Stem Cell therapy, and gene therapy information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; providing medical information; services in the extraction of cells from patients in the nature of stem cell therapy services; manipulation of cells for therapeutic pu...

Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations and drugs in the field of immunotherapy; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations and drugs in the field cell therapy
gcc19cart

General Information


Serial Number97029671
Word MarkGCC19CART
Filing DateWednesday, September 15, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, May 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements


Goods and ServicesStem cell therapy services; Immunotherapy services in the nature of medical services; collection and preservation of biological tissue, blood and cells; Medical diagnostic testing, monitoring, and reporting services; Medical treatment of of cancer such as colon carcinoma, lymphoid malignancy, pancreatic cancer, breast cancer, lung cancers, ovarian cancer, prostate cancer, and autoimmune diseases such as Systemic lupus erythematosus (SLE); Health care services, namely, providing a database in the field of cell therapy such as Chimeric Antigen Receptor therapy, TCR (T-Cell Receptor) therapy, TIL (tumor-infiltrating lymphocyte) therapy, Natural Killer (NK) cell therapy, and Stem Cell therapy, and gene therapy information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; providing medical information; services in the extraction of cells from patients in the nature of stem cell therapy services; manipulation of cells for therapeutic purposes in the nature of stem cell therapy services; reinsertion of cells into human patients in the nature of stem cell therapy services
Goods and ServicesScientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations and drugs in the field of immunotherapy; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations and drugs in the field cell therapy

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 19, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 21, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameInnovative Cellular Therapeutics Holdings, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRockville, MD 20850

Party NameInnovative Cellular Therapeutics Holdings, Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRockville, MD 20850

Trademark Events


Event DateEvent Description
Wednesday, January 18, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 18, 2021NEW APPLICATION ENTERED
Thursday, October 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 17, 2022ASSIGNED TO EXAMINER
Monday, July 18, 2022NON-FINAL ACTION WRITTEN
Monday, July 18, 2022NON-FINAL ACTION E-MAILED
Monday, July 18, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 18, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 21, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 6, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 6, 2023SOU EXTENSION 1 FILED
Wednesday, December 6, 2023SOU EXTENSION 1 GRANTED
Friday, December 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 29, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 29, 2024SOU EXTENSION 2 FILED
Wednesday, May 29, 2024SOU EXTENSION 2 GRANTED
Thursday, May 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED